S.a. Ipsen, - Net Worth and Insider Trading

S.a. Ipsen, Net Worth

The estimated net worth of S.a. Ipsen, is at least $111 Million dollars as of 2024-11-10. S.a. Ipsen, is the 10% Owner of Rhythm Pharmaceuticals Inc and owns about 1,646,198 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $111 Million. Details can be seen in S.a. Ipsen,'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that S.a. Ipsen, has not made any transactions after 2017-10-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of S.a. Ipsen,

To

S.a. Ipsen, Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, S.a. Ipsen, owns 2 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , and Radius Health Inc (RDUS) .

Click here to see the complete history of S.a. Ipsen,’s form 4 insider trades.

Insider Ownership Summary of S.a. Ipsen,

Ticker Comapny Transaction Date Type of Owner
RYTM Rhythm Pharmaceuticals Inc 2017-10-10 10 percent owner
RDUS Radius Health Inc 2011-05-17 other: Possible 10% beneficial owner

S.a. Ipsen, Latest Holdings Summary

S.a. Ipsen, currently owns a total of 1 stock. S.a. Ipsen, owns 1,646,198 shares of Rhythm Pharmaceuticals Inc (RYTM) as of October 10, 2017, with a value of $111 Million.

Latest Holdings of S.a. Ipsen,

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RYTM Rhythm Pharmaceuticals Inc 2017-10-10 1,646,198 67.33 110,838,511

Holding Weightings of S.a. Ipsen,


S.a. Ipsen, Form 4 Trading Tracker

According to the SEC Form 4 filings, S.a. Ipsen, has made a total of 0 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years. The most-recent trade in Rhythm Pharmaceuticals Inc is the acquisition of 20,000 shares on October 10, 2017, which cost S.a. Ipsen, around $340,000.

Insider Trading History of S.a. Ipsen,

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

S.a. Ipsen, Trading Performance

GuruFocus tracks the stock performance after each of S.a. Ipsen,'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by S.a. Ipsen, is 2.61%. GuruFocus also compares S.a. Ipsen,'s trading performance to market benchmark return within the same time period. The performance of stocks bought by S.a. Ipsen, within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how S.a. Ipsen,'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of S.a. Ipsen,

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.16 LIMIT LIMIT LIMIT LIMIT LIMIT

S.a. Ipsen, Ownership Network

Ownership Network List of S.a. Ipsen,

No Data

Ownership Network Relation of S.a. Ipsen,

Insider Network Chart

S.a. Ipsen, Owned Company Details

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

S.a. Ipsen, is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, S.a. Ipsen, made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 85,162 shares made by Pamela J. Cramer , and a net sale of 78,894 shares made by Jennifer Chien .

In summary, during the past 3 months, insiders sold 135,174 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 135,174 shares. During the past 18 months, 592,041 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 592,041 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

S.a. Ipsen, Mailing Address

Above is the net worth, insider trading, and ownership report for S.a. Ipsen,. You might contact S.a. Ipsen, via mailing address: 42, Rue Du Docteur Blanche, Paris I0 75016.